Abiopharma

🔍 Ye Gang (Executive)

Company: Sea Ltd (SE)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 7,181 shares of Class A ordinary shares at $122.57 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 392,819.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 7,989 shares of Class A ordinary shares at $123.48 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 384,830.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 8,116 shares of Class A ordinary shares at $124.38 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 376,714.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 3,900 shares of Class A ordinary shares at $125.44 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 372,814.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 2,289 shares of Class A ordinary shares at $126.51 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 370,525.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 525 shares of Class A ordinary shares at $127.45 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 370,000.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 11,733 shares of Class A ordinary shares at $121.84 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 358,267.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 10,807 shares of Class A ordinary shares at $122.66 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 347,460.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 6,381 shares of Class A ordinary shares at $123.78 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 341,079.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 1,079 shares of Class A ordinary shares at $124.64 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 340,000.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Holds 0 shares of Class A ordinary shares (Direct)
  Date: 2026-08-13 | Code: H | shares_owned_after: 21,176,405.00

Footnotes:

• F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by a BVI entity controlled by the Reporting Person on September 4, 2025.
• F2: Represents the weighted average price of shares sold at prices that ranged from $121.93 to $122.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F3: Represents the weighted average price of shares sold at prices that ranged from $122.98 to $123.928.
• F4: Represents the weighted average price of shares sold at prices that ranged from $123.93 to $124.89.
• F5: Represents the weighted average price of shares sold at prices that ranged from $124.93 to $125.92.
• F6: Represents the weighted average price of shares sold at prices that ranged from $125.93 to $126.83.
• F7: Represents the weighted average price of shares sold at prices that ranged from $121.25 to $122.24.
• F8: Represents the weighted average price of shares sold at prices that ranged from $122.26 to $123.25.
• F9: Represents the weighted average price of shares sold at prices that ranged from $123.31 to $124.11.
• F10: Represents the weighted average price of shares sold at prices that ranged from $124.42 to $125.00.